SRSF2 and renal carcinoma: In clear cell renal cell carcinomas, SRSF2 is commonly decreased and knockdown of SRSF2 in renal cancer-derived cell lines results in decreased expression of MCL1S isoforms and inhibiting the apoptotic pathways [50].